Promising results from comparative study with Episealer® accepted for presentation at German orthopaedic congress
Episurf Medical (Nasdaq: EPIS B) today announces that the abstract “Comparable clinical outcomes after autologous matrix-induced chondrogenesis versus implantation of single patient-specific metal implants in focal femoral chondral lesions of the middle-aged patient” has been accepted for a podium presentation at the German Congress of Orthopaedics and Traumatology, DKOU 2022, which will take place in Berlin, Germany, on October 25-28, 2022. The presentation will be held by Priv.-Doz. Dr. med. Clemens Kösters, Maria-Josef-Hospital Greven, Germany. “We have come to a stage where our